Advancing Cell And Gene Therapy Development With Digital PCR

Cell and gene therapies offer new hope for once-untreatable diseases, but moving from discovery to clinical application requires rigorous quality control at every step. This catalog presents a complete portfolio of digital PCR-based tools designed to support safety, potency, and purity testing across the CGT workflow.

From plasmid prep to viral vector production, in-process QC, and final release, explore validated dPCR assays for AAV/LV titer, transgene integrity, VCN, mycoplasma, residual host cell DNA, and more—all powered by the QIAcuity® Digital PCR System and 21 CFR Part 11-compliant software.

Access the full brochure to see how QIAcuity solutions accelerate CGT development with precision, scalability, and compliance.